Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin

NCT03853421 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety and Tolerability

Interventions

DRUG: Sevuparin

Sponsor

Modus Therapeutics AB